NSAIDs Found to Be of Little Benefit to Patients With Back Pain

This article originally appeared here.
Share this content:
NSAIDs Found to Be of Little Benefit to Patients With Back Pain
NSAIDs Found to Be of Little Benefit to Patients With Back Pain

THURSDAY, Feb. 2, 2017 (HealthDay News) -- Nonsteroidal anti-inflammatory drugs (NSAIDs) don't help most patients with back pain, according to a review published online Feb. 2 in the Annals of the Rheumatic Diseases.

Gustavo Machado, a research fellow with the George Institute for Global Health in Sydney, and colleagues examined 35 studies on the use of NSAIDs to treat back pain. The studies tracked about 6,000 patients.

The researchers estimated that only one in six patients gained a benefit from taking NSAIDs. The investigators also found that participants taking the drugs were 2.5 times more likely to experience gastrointestinal side effects, compared with those who took placebos.

"NSAIDs are effective for spinal pain, but the magnitude of the difference in outcomes between the intervention and placebo groups is not clinically important," the authors write. "At present, there are no simple analgesics that provide clinically important effects for spinal pain over placebo. There is an urgent need to develop new drug therapies for this condition."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Aspirin, Rivaroxaban Similar After Total Hip, Knee Arthroplasty

Aspirin, Rivaroxaban Similar After Total Hip, Knee Arthroplasty

Extended prophylaxis with aspirin no different from rivaroxaban for preventing venous thromboembolism

Odds of ARDS Up After Cardiac Surgery During Flu Season

Odds of ARDS Up After Cardiac Surgery During ...

Cardiac surgery during flu season is independent risk factor for acute respiratory distress syndrome

In A-Fib Patients, Stroke Risk Higher for Blacks Than Whites

In A-Fib Patients, Stroke Risk Higher for Blacks ...

Higher risk of ischemic stroke seen before, after atrial fibrillation diagnosis compared with whites

is free, fast, and customized just for you!

Already a member?

Sign In Now »